乌鸦传媒

Nicolas Girard, MD, PhD, explains the SOHO-01 study

"It really does appear to be superior in most ways," says Jorge Nieva, MD

The addition of SABR appears to provide PFS, OS benefit when considered against historical data

With a growing number of relevant markers, testing rates remain tragically low, Jack West says

Nicholas Rohs believes IMpower010 is "definitely an impactful study"